Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan nanoparticles loaded with Minoxidil were effective for hair growth but released the drug more slowly than the amphiphilic derivative.

Transdermal exposure to certain steroids can be detected in urine for up to 14 days.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Liposomes improve minoxidil delivery to hair follicles, enhancing treatment for hair loss.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Using both topical and oral minoxidil does not reduce hair shedding.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Essential oils in a nanoemulsion help hair grow better than minoxidil 2% in mice.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.

Combining microneedling with 2% minoxidil is more effective and safe for treating female pattern hair loss than using minoxidil alone.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

Low-dose oral minoxidil effectively promotes hair growth with minimal side effects.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Granules improve hair loss treatment by targeting follicles.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Nanocrystals and nanoparticles can enhance drug delivery for skin applications by improving solubility and dissolution rates.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

DMSO-liposomes improve finasteride delivery for hair loss treatment.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Created tablet similar to Avodart using γ-cyclodextrin and solubilizers.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Testosterone is important for women's health, but more research is needed to guide its use.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.